Clever Leaves Holdings Inc. (NASDAQ: CLVR) is a vertically integrated medical cannabis company engaged in the cultivation, processing, manufacturing and distribution of pharmaceutical-grade cannabinoid products. Since its inception, the company has built a global platform designed to meet the rigorous quality and compliance standards required by international regulators. Clever Leaves focuses on producing dried flower, extracts and finished dose formulations that serve the evolving needs of patients and healthcare providers.
The company operates large-scale cultivation facilities in Colombia and Portugal, both of which comply with Good Manufacturing Practices (GMP). These facilities leverage Colombia’s near-equatorial climate to reduce energy consumption during cultivation, while Portugal’s high-tech greenhouse complexes ensure year-round production and stringent environmental controls. Clever Leaves uses a combination of proprietary cultivation techniques, solvent-less extraction methods and precision formulation capabilities to deliver consistent cannabinoid profiles and novel delivery forms.
Clever Leaves sells its products into a growing portfolio of markets across North America, Europe and Latin America. Its customer base includes licensed pharmaceutical distributors, research institutions and select wellness brands seeking pharmaceutical-grade inputs. The company has established supply agreements in Germany, the United Kingdom and Canada, and is positioning itself to serve emerging medical markets in the United States and other jurisdictions where regulatory frameworks are evolving.
Under the leadership of CEO James C. Miller III and an executive team with deep experience in pharmaceuticals, agriculture and regulatory affairs, Clever Leaves has prioritized strategic partnerships and product innovation. The company continues to expand its research and development efforts, exploring novel botanical extractions and advanced delivery systems. With a focus on quality, compliance and scalable production, Clever Leaves aims to meet the long-term needs of the global medical cannabis industry.
AI Generated. May Contain Errors.